Clot Retriever Device won another honor: Provincial Precision Medicine Science and Technology Award

Recently, the Guangdong Precision Medicine Application Association released the "Notice on the Award of the 2021 Guangdong Precision Medicine Science and Technology Award", and officially announced the 2021 Guangdong Precision Medicine Science and Technology Award winners.

Zhuhai Ton-Bridge Medical Technology Co., Ltd. won the second prize of Science and Technology Innovation Award for the achievement of "Ischemic Stroke Helical Open Clot Retriever Device".

The "Guangdong Provincial Precision Medicine Science and Technology Award" was established with the approval of the Guangdong Provincial Science and Technology Award Review Committee, and the review work will be officially launched in 2021. This is also the country's first science and technology award featuring precision medicine.

This project is to develop a new generation of high-level domestic clot retriever device, which can be used to restore blood flow by mechanically removing thrombus blocked in intracranial blood vessels when patients suffer from acute ischemic stroke.

news1 (1)

The Clot Retriever Device is designed as an open structure with an "S"-shaped side spiraling upward, a classic crimped stent structure, which can obtain appropriate radial support force when the stent is released, self-expand quickly and quickly fit the blood vessel wall to form a blood flow recovery channel. It has the advantages of good thrombus clamping force, no damage to the vascular intima, and the thrombus is not easy to fall off during the withdrawal process.

The Clot Retriever Device is supported by a number of independent intellectual property rights, and has obtained the Class III medical device registration certificate and EU CE certification, and has received rave reviews in clinical applications.

news1 (2)
news1 (3)

The promotion and application of the project's product, the Clot Retriever Device are of great significance to promoting scientific and technological progress in the field of neuroimplantation and interventional medical devices and realizing "domestic substitution of imports". It has extremely high economic and social benefits and has broad application prospects.

Post time: Apr-19-2022